Results 71 to 80 of about 475,707 (262)

Tobacco use and cessation counseling in a population of health professions students in South Africa [PDF]

open access: yes, 2011
Includes bibliographical references.Tobacco is a leading risk factor for the global burden of disease in both developed and developing countries. The morbidity and mortality caused by tobacco can be prevented efficaciously and cost-effectively by active ...
Tsai, Yu-Chia
core   +1 more source

State Leadership Academies to reduce cigarette smoking among people with behavioral health conditions in the United States

open access: yesPreventive Medicine Reports
Objective: Smoking is concentrated in behavioral health populations in the United States, calling for efforts to increase access to cessation services.
M. Vijayaraghavan   +8 more
doaj   +1 more source

Smoking cessation and tobacco prevention in Indigenous populations [PDF]

open access: yes, 2014
This article systematically reviews 91 smoking cessation and tobacco prevention studies tailored for Indigenous populations around the world, with a particular focus on Aboriginal and Torres Strait Islander populations in Australia. We identified several
Malcolm Brinn   +9 more
core  

Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors [PDF]

open access: yes, 2010
Rationale: Neurobiological models of addiction suggest that abnormalities of brain reward circuitry distort salience attribution and inhibitory control processes, which in turn contribute to high relapse rates.
Jane Powell   +16 more
core   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Cytisine Use Vs Nicotine Replacement Therapy in Relapsed Smokers with Heart Disease: Feasibility Results from a Pilot Randomized Trial

open access: yesCJC Open
Background: Cytisine use has proven efficacy for smoking cessation. We plan to investigate whether cytisine use is effective for relapse recovery and conducted a pilot randomized trial to assess the feasibility of a definitive trial.
Hassan Mir, MD, MHI, MPH, FRCPC, FACP   +8 more
doaj   +1 more source

Using a realist approach to evaluate smoking cessation interventions targeting pregnant women and young people [PDF]

open access: yes, 2010
Background This paper describes a study protocol designed to evaluate a programme of smoking cessation interventions targeting pregnant women and young people living in urban and rural locations in Northeast Scotland.
Denise A Gray   +14 more
core   +2 more sources

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

The development and evaluation of a smoking cessation programme for disadvantaged pregnant women in South Africa [PDF]

open access: yes, 2011
Studies of smoking during pregnancy in South Africa have found exceptionally high smoking rates among disadvantaged women of mixed ethnic descent (46%) (Steyn et al., 1997; Petersen et al., 2009a).
Everett-Murphy Katherine
core   +1 more source

A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders

open access: yesBJPsych Open
Background Cannabis use severely affects the outcome of people with psychotic disorders, yet there is a lack of treatments. To address this, in 2019 the National Health Service (NHS) Cannabis Clinic for Psychosis (CCP) was developed to support adults ...
Marta Di Forti   +22 more
doaj   +1 more source

Home - About - Disclaimer - Privacy